Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LRMR - Larimar Therapeutics, Inc.
30 K
LAST VALUE
-96.12%
2 YEAR CAGR
-78.60%
5 YEAR CAGR
-51.38%
10 YEAR CAGR